Page 3 - Codexis Daily News Today

StockNews.com downgraded shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a report released on Tuesday morning. Several other analysts have also recently weighed in on CDXS. Stifel Nicolaus dropped their price objective on shares of Codexis from $9.00 to $5.00 and set a buy rating for the […]

Codexis, Inc. (NASDAQ:CDXS – Get Free Report) insider Margaret Nell Fitzgerald purchased 11,834 shares of the stock in a transaction that occurred on Friday, September 8th. The stock was purchased at an average price of $1.70 per share, for a total transaction of $20,117.80. Following the acquisition, the insider now owns 81,420 shares in the […]

Benchmark restated their buy rating on shares of Codexis (NASDAQ:CDXS – Free Report) in a research note released on Friday, Benzinga reports. Benchmark currently has a $9.00 price objective on the biotechnology company’s stock. CDXS has been the subject of several other reports. HC Wainwright cut Codexis from a buy rating to a neutral rating […]

StockNews.com began coverage on shares of Codexis (NASDAQ:CDXS – Free Report) in a report released on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other brokerages also recently weighed in on CDXS. Stifel Nicolaus decreased their price objective on shares of Codexis from $9.00 to $5.00 and […]

Shares of Codexis, Inc. (NASDAQ:CDXS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]

Codexis, Inc. (NASDAQ:CDXS – Get Free Report) saw a significant drop in short interest in July. As of July 31st, there was short interest totalling 2,750,000 shares, a drop of 6.5% from the July 15th total of 2,940,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the short-interest ratio is presently 2.6 […]

Codexis (NASDAQ:CDXS – Free Report) had its target price trimmed by Stifel Nicolaus from $9.00 to $5.00 in a report issued on Monday, MarketBeat Ratings reports. The brokerage currently has a buy rating on the biotechnology company’s stock. Several other equities research analysts have also issued reports on the stock. HC Wainwright lowered shares of […]

White Pine Capital LLC increased its position in Codexis, Inc. (NASDAQ:CDXS – Free Report) by 13.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 249,106 shares of the biotechnology company’s stock after purchasing an additional 29,366 shares during the quarter. White Pine Capital LLC […]

White Pine Capital LLC raised its holdings in shares of Codexis, Inc. (NASDAQ:CDXS – Free Report) by 13.4% during the first quarter, according to its most recent filing with the SEC. The firm owned 249,106 shares of the biotechnology company’s stock after purchasing an additional 29,366 shares during the period. White Pine Capital LLC’s holdings […]

Codexis (NASDAQ:CDXS – Get Free Report) was downgraded by stock analysts at TD Cowen from an “outperform” rating to a “market perform” rating in a report issued on Monday, Marketbeat reports. They currently have a $4.00 price objective on the biotechnology company’s stock, down from their prior price objective of $21.00. TD Cowen’s price objective […]